Publications by BIONET members (English)

Bauer, S. & Wahlberg, A. (eds.) 2009 Contested Categories: Life Sciences in Society, Aldershot: Ashgate.

Chen, H. 2009 ‘Stem cell governance in China: from bench to bedside?’, New Genetics and Society, 28(3): 267-282.

Cong, Y. 2007 ‘From Chinese Values of Life to Explore the Ethical Aspects of Stem Cell Research in Mainland China’, Contemporary Chinese Thought 2(Winter 2007-08): 18-31.

Cong, Y. 2004 ‘Artificial insemination and happiness‘ Eubios Journal of Asian and International Bioethics 14: 48-9.

Döring, O. 2009 ‘Probing the Trial of Medical Trials: Chinese – European Collaborations; A Conference Report’,  Journal of International Biotechnology Law 6(1): 41.

Döring, O. 2008 ‘The possible role of religion in secular bioethics. Reflexions on the case of China’, Kwan, T-W (ed.) Responsibility and Commitment: Eighteen Essays in Honor of Gerhold K. Becker, Waldkirch: Edition Gorz: 249-264

Döring, O. 2008 ‘What’s in a choice? Ethical, cultural and social dimension of sex selection in China‘, human_ontogenetics 2(1), 2008: 11-24.

Döring, O. 2007 ‘Limits of Human Existence According to China’s Bioethics’, in Düwell, M., Rehmann-Sutter, C., and Mieth, D. (eds.) The Contingent Nature of Life. Bioethics and Limits of Human Existence. Dordrecht: Springer. 2007: 289-303.

Döring, O. 2006 ‘Steering between Humanitarian Medicine and the Commodity Market: China Sets Out to Govern Human Organ Transplants’, CHINA aktuell – Journal of Current Chinese Affairs 4: 83-98.

Döring, O. 2006 ‘Biomedical Research and Ethical Regulations in China: Some Observations about Gene Therapy, Human Research, and Struggles of Interest’ in Niewöhner, J. and Tannert, C. (eds.), Gene Therapy: Prospective Technology Assessment in its Societal Context. Amsterdam: Elsevier: 143-58.

Döring, O. 2003 ‘China’s Struggle for Practical Regulations in Medical Ethics‘, Nature Reviews Genetics 4: 233-9.

Düwell, M., Rehmann-Sutter, C., and Mieth, D. (eds.) 2007 The Contingent Nature of Life. Bioethics and Limits of Human Existence, Dordrecht: Springer.

Gottweis, H. 2009 ‘Biopolitics in Asia’, New Genetics and Society, 28(3): 201-4.

Gottweis, H. & Kim, B. 2009 ‘Bionationalism, stem cells, BSE, and Web 2.0 in South Korea: toward the reconfiguration of biopolitics’, New Genetics and Society, 28(3): 223-39.

Gottweis, H., Salter B, and Waldby C., 2009 The Global Politics of Human Stem Cell Science: Regenerative Medicine in Transition, London: Palgrave.

Gottweis, H. and Minger, S. 2008 ‘iPS cells and the politics of promise‘ Nature Biotechnology, 26(3): 271-2.

Gottweis, H. and Petersen, A. (eds.) 2007 Biobanks: Governance in Comparative Perspective. London: Routledge.

Gottweis, H. and Zatloukal, K. 2007 ‘Biobank Governance: Trends and Perspectives‘,Pathobiology, 74: 206-11.

Gottweis, H. and Triendl, R. 2006 ‘South Korean policy failure and the Hwang debacle‘ Nature Biotechnology, 24: 141-3.

Gottweis, H. and Prainsack, P. 2006 ‘Emotion in political discourse: Contrasting approaches to stem cell governance: the US, UK, Israel, and Germany‘, Regenerative Medicine, 1(6): 823-9.

Haimes, E., Porz, R., Leach Scully, J. and Rehmann-Sutter, C. 2008 ‘‘So, what is an embryo?’ A comparative study of the views of those asked to donate embryos for hESC research in the UK and Switzerland‘, New Genetics and Society, 27(2): 113-26.

Hennig, W. 2009 ‘Research in China : Experiences from 23 years of molecular genetics research in Shanghai‘, EMBO reports, 10(6): 545-50.

Hennig, W. 2006 ‘Bioethics in China: Although national guidelines are in place, their implementation remains difficult‘, EMBO reports, 7(9): 850-4.

Li, LJ. and Lu, GX. 2005 ‘How medical ethical principles are applied in treatment with artificial insemination by donors (AID) in Hunan, China: effective practice at the Reproductive and Genetic Hospital of CITIC-Xiangya‘, Journal of Medical Ethics, 31: 333-7.

Qiu, R. 2006 ‘Cloning Issues in China’, in Roetz, H. (ed.) Cross-Cultural Issues in Bioethics: The Example of Human Cloning. Amsterdam, New York: Rodopi:.51-75.

Qiu, R. 2001 ‘Sociocultural dimensions of infertility and assisted reproduction in the Far East’ in Current Practices and Controversies in Assisted Reproduction, Report of a meeting on “Medical, Ethical and Social Aspects of Assisted Reproduction” WHO Headquarters, Geneva, Switzerland, 17-21 September 2001

Rehmann-Sutter, C., and Müller, H. 2009 Disclosure Dilemmas: Ethics of Genetic Prognosis after the ‘Right to Know/Not to Know’ Debate, Aldershot: Ashgate.

Rehmann-Sutter, C., Porz, R. and Leach Scully, J. 2008 ‘Sourcing human embryonic tissue: the ethical issues’, in H. Wiesmann (ed) Fundamentals of Tissue Engineering and Regenerative Medicine, London: Springer.

Rose, N. 2008 ‘The value of life: somatic ethics & the spirit of biocapital‘, Daedalus, 137(1): 36-48.

Rose, N. 2007 ‘Beyond medicalisation’, The Lancet, 369: 700-1.

Rose, N. 2007 ‘Molecular Biopolitics, Somatic Ethics and the Spirit of Biocapital‘, Social Theory and Health, 5(1): 3-29.

Rose, N. and Rabinow, P. 2006 ‘Biopower today‘, BioSocieties, 1, 2, 195-218.

Rose, N. 2006 The politics of life itself : biomedicine, power, and subjectivity in the twenty-first century, Princeton, Princeton University Press.

Singh, I. & Rose, N. 2009 ‘Biomarkers in psychiatry: Promises and perils in the real world‘,Nature, 460(7252): 202-7.

Sleeboom-Faulkner, M. and Patra, PK. 2008 ‘The Bioethical Vacuum: national policies on human embryonic stem cell research in India and China’, Journal of International Biotechnology Law, 5(6): 221-34.

Sleeboom-Faulkner, M. (ed.) 2009 Human Genetic Biobanks in Asia: Politics of Trust and Scientific Advancement, London: Routledge.

Sleeboom-Faulkner, M. 2008 ‘The Changing Nature of Ideology in the Life Sciences in Mainland China: Case-studies of Human Cloning and Human Embryonic Stem Cell Research (hESR) in Medical Textbooks (1996-2005)’, BioSocieties 3(1): 21-36.

Sleeboom-Faulkner, M. 2007 ‘Social-science perspectives on bioethics: Predictive Genetic Testing (PGT) in Asia‘, Journal of Bioethical Inquiry, 4(3): 197-206.

Sleeboom-Faulkner, M. 2007 ‘Predictive Genetic Testing in Asia: Social Science Perspectives on the Bioethics of Choice‘, Journal of Bioethical Inquiry, 4(3): 193-5.

Sleeboom-Faulkner, M. and Sui, S. 2007 ‘Commercial genetic testing in mainland China: Social, financial and ethical issues‘, Journal of Bioethical Inquiry, 4(3): 229-37.

Sleeboom-Faulkner, M. 2006 ‘How to define a population: Cultural politics of genetic sampling in the People’s Republic of China and the Republic of China‘, BioSocieties, 1(4): 399-419.

Sleeboom-Faulkner, M. (ed.) 2004 Genomics in Asia : a clash of bioethical interests?. London: Kegan Paul International.

Wahlberg, A. 2009 ‘Bodies and populations: life optimization in Vietnam’, New Genetics and Society, 28(3): 241-51.

Wahlberg, A. 2008 ‘Reproductive medicine and the concept of ‘quality’‘, Clinical Ethics, 3(4): 189-93.

Wahlberg, A. 2008 ‘Above and beyond superstition – western herbal medicine and the decriminalising of placebo‘, History of the Human Sciences, 21(1): 77-101.

Wahlberg, A. 2008 ‘Pathways to Plausibility: When Herbs Become Pills‘, BioSocieties, 3(1): 37-56

Wahlberg, A. 2007 ‘Measuring progress – calculating the life of nations‘, Distinktion – Scandinavian Journal of Social Theory, 14, 65-82.

Wahlberg, A. and McGoey, L. 2007, ‘An elusive evidence base – the construction and governance of randomised controlled trials‘, BioSocietiesSpecial issue ‘The Construction and Governance of Randomised Controlled Trials’, 2(1): 1-10.

Wahlberg, A. & Streitfellner, T. 2009 ‘Tourisme de cellules souches, désespoir et pouvoir des nouvelles thérapies [Stem cell tourism, desperation and the governing of new therapies]’ in Leibing, A. & Tournay, V. (eds.) Technologies de l’espoir. Les débats publics autour de l’innovation médicale – un objet anthropologique à définir, Québec : Presses Universitaires de Laval, collection Société, cultures et santé.

Zhai, X. 2004 ‘ABA Country Report for China 2003‘ Eubios Journal of Asian and International Bioethics 14:1 5-10.